Clinical and pathophysiological implications of chromosomal alterations in adrenocortical tumors: An integrated genomic approach

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 2, 2012, Pages

  Barreau, Olivia ^a,d,e   De Reynies, Aurélien ^f   Wilmot Roussel, Hortense ^a,d,e   Guillaud Bataille, Marine ^a,c,e   Auzan, Colette ^a,e   René Corail, Fernande ^a,e   Tissier, Frédérique ^a,c,d,e   Dousset, Bertrand ^a,c,d,e   Bertagna, Xavier ^a,b,c,d,e   Bertherat, Jérôme ^a,c,d,e   Clauser, Eric ^c   Assié, Guillaume ^a,c,d,e  

^a INSERM   (France)

^b INSTITUT NATIONAL DU CANCER   (France)

^c Hôpital Cochin ^*  (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e CNRS   (France)

^f Cartes d'Identité des Tumeurs Program Ligue Nationale Contre le Cancer   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CHROMOSOMAL LOCALIZATION; CHROMOSOME 12; CHROMOSOME 13; CHROMOSOME 16; CHROMOSOME 19; CHROMOSOME 20; CHROMOSOME 22; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DNA MARKER; FEMALE; GENE CLUSTER; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE LOSS; GENETIC GAIN; GENETIC IDENTIFICATION; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION;

ADENOMA; ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHROMOSOME ABERRATIONS; COHORT STUDIES; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; FEMALE; GENOMICS; HUMANS; MALE; MIDDLE AGED; SYSTEMS INTEGRATION; YOUNG ADULT;

EID: 84856786614     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1588     Document Type: Article

References (47)

1. Bertherat J, Mosnier-Pudar H, Bertagna X 2002 Adrenal incidentalomas. Curr Opin Oncol 14:58-63 (Pubitemid 34072965)
2. Libè R, Fratticci A, Bertherat J 2007 Adrenocortical cancer: pathophysiology and clinical management. Endocr Relat Cancer 14:13-28 (Pubitemid 47521719)
3. Abiven G, Coste J, Groussin L, Anract P, Tissier F, Legmann P, Dousset B, Bertagna X, Bertherat J 2006 Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. J Clin Endocrinol Metab 91:2650-2655 (Pubitemid 44024632)
4. Fassnacht M, Allolio B 2009 Clinical management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab 23:273-289
5. Schteingart DE, Doherty GM, Gauger PG, Giordano TJ, Hammer GD, Korobkin M, Worden FP 2005 Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 12:667-680 (Pubitemid 41483000)
6. Weiss LM, Medeiros LJ, Vickery Jr AL 1989 Pathological features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13:202-206 (Pubitemid 19081702)
7. Lau SK, Weiss LM 2009 The Weiss system for evaluating adrenocortical neoplasms: 25 years later. Hum Pathol 40:757-768
8. Weiss LM 1984 Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 8:163-169 (Pubitemid 14166767)
9. Pohlink C, Tannapfe A, Eichfeld U, Schmidt F, Führer D, Paschke R, Koch CA 2004 Does tumor heterogeneity limit the use of the Weiss criteria in the evaluation of adrenocortical tumors? J Endocrinol Invest 27:565-569 (Pubitemid 39255508)
10. Volante M, Buttigliero C, Greco E, Berruti A, Papotti M 2008 Pathological and molecular features of adrenocortical carcinoma: an update. J Clin Pathol 61:787-793 (Pubitemid 351969722)
11. de Fraipont F, El Atifi M, Cherradi N, Le Moigne G, Defaye G, Houlgatte R, Bertherat J, Bertagna X, Plouin PF, Baudin E, Berger F, Gicquel C, Chabre O, Feige JJ 2005 Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy. J Clin Endocrinol Metab 90:1819-1829 (Pubitemid 40464057)
12. Gicquel C, Raffin-Sanson ML, Gaston V, Bertagna X, Plouin PF, Schlumberger M, Louvel A, Luton JP, Le Bouc Y 1997 Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors. J Clin Endocrinol Metab 82:2559-2565 (Pubitemid 27337873)
13. Giordano TJ, Thomas DG, Kuick R, Lizyness M, Misek DE, Smith AL, Sanders D, Aljundi RT, Gauger PG, Thompson NW, Taylor JM, Hanash SM 2003 Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am J Pathol 162:521-531 (Pubitemid 36267859)
14. Gicquel C, Bertagna X, Gaston V, Coste J, Louvel A, Baudin E, Bertherat J, Chapuis Y, Duclos JM, Schlumberger M, Plouin PF, Luton JP, Le Bouc Y 2001 Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res 61:6762-6767 (Pubitemid 32896498)
15. de Reyniès A, Assié G, Rickman DS, Tissier F, Groussin L, René-Corail F, Dousset B, Bertagna X, Clauser E, Bertherat J 2009 Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J Clin Oncol 27:1108-1115
16. Slater EP, Diehl SM, Langer P, Samans B, Ramaswamy A, Zielke A, Bartsch DK 2006 Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors. Eur J Endocrinol 154:587-598
17. Velázquez-Fernández D, Laurell C, Geli J, Höög A, Odeberg J, Kjellman M, Lundeberg J, Hamberger B, Nilsson P, Bäckdahl M 2005 Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy. Surgery 138:1087-1094 (Pubitemid 41797349)
18. Giordano TJ, Kuick R, Else T, Gauger PG, Vinco M, Bauersfeld J, Sanders D, Thomas DG, Doherty G, Hammer G 2009 Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin Cancer Res 15:668-676
19. Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, Terzolo M, Mueller HH, Hahner S, Allolio B 2009 Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a revised TNM classification. Cancer 115:243-250
20. Macfarlane DA 1958 Cancer of the adrenal cortex: the natural history, prognosis, and treatment in a study of fifty-five cases. Ann R Coll Surg Engl 23:155-186
21. Assié G, Antoni G, Tissier F, Caillou B, Abiven G, Gicquel C, Leboulleux S, Travagli JP, Dromain C, Bertagna X, Bertherat J, Schlumberger M, Baudin E 2007 Prognostic parameters of metastatic adrenocortical carcinoma. J Clin Endocrinol Metab 92:148-154 (Pubitemid 46067523)
22. Dohna M, Reincke M, Mincheva A, Allolio B, Solinas-Toldo S, Lichter P 2000 Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high-level amplifications. Genes Chromosomes Cancer 28:145-152 (Pubitemid 30246992)
23. Kjellman M, Kallioniemi OP, Karhu R, Hög A, Farnebo LO, Auer G, Larsson C, Bäckdahl M 1996 Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy. Cancer Res 56:4219-4223 (Pubitemid 26305019)
24. Sidhu S, Marsh DJ, Theodosopoulos G, Philips J, Bambach CP, Campbell P, Magarey CJ, Russell CF, Schulte KM, Röher HD, Delbridge L, Robinson BG 2002 Comparative genomic hybridization analysis of adrenocortical tumors. J Clin Endocrinol Metab 87:3467-3474 (Pubitemid 34816405)
25. Zhao J, Roth J, Bode-Lesniewska B, Pfaltz M, Heitz PU, Komminoth P 2002 Combined comparative genomic hybridization and genomic microarray for detection of gene amplifications in pulmonary artery intimal sarcomas and adrenocortical tumors. Genes Chromosomes Cancer 34:48-57 (Pubitemid 34260596)
26. Zhao J, Speel EJ, Muletta-Feurer S, Rütimann K, Saremaslani P, Roth J, Heitz PU, Komminoth P 1999 Analysis of genomic alterations in sporadic adrenocortical lesions. Gain of chromosome 17 is an early event in adrenocortical tumorigenesis. Am J Pathol 155:1039-1045 (Pubitemid 29488910)
27. Gruschwitz T, Breza J, Wunderlich H, Junker K 2010 Improvement of histopathological classification of adrenal gland tumors by genetic differentiation. World J Urol 28:329-334
28. Stephan EA, Chung TH, Grant CS, Kim S, Von Hoff DD, Trent JM, Demeure MJ 2008 Adrenocortical carcinoma survival rates correlated to genomic copy number variants. Mol Cancer Ther 7:425-431 (Pubitemid 351302536)
29. Szabó PM, Tamási V, Molnár V, Andrásfalvy M, Tömböl Z, Farkas R, Kövesdi K, Patócs A, Tóth M, Szalai C, Falus A, Rácz K, Igaz P 2010 Meta-analysis of adrenocortical tumour genomics data: novel pathogenic pathways revealed. Oncogene 29:3163-3172
30. d'Alva CB, Abiven-Lepage G, Viallon V, Groussin L, Dugue MA, Bertagna X, Bertherat J 2008 Sex steroids in androgen-secreting adrenocortical tumors: clinical and hormonal features in comparison with non-tumoral causes of androgen excess. Eur J Endocrinol 159:641-647
31. Levine AC, Mitty HA, Gabrilove JL 1988 Steroid content of the peripheral and adrenal vein in Cushing's syndrome due to adrenocortical adenoma and carcinoma. J Urol 140:11-15
32. Terzolo M, Alì A, Osella G, Reimondo G, Pia A, Peretti P, Paccotti P, Angeli A 2000 The value of dehydroepiandrosterone sulfate measurement in the differentiation between benign and malignant adrenal masses. Eur J Endocrinol 142:611-617 (Pubitemid 30399492)
33. Jain AN, Tokuyasu TA, Snijders AM, Segraves R, Albertson DG, Pinkel D 2002 Fully automatic quantification of microarray image data. Genome Res 12:325-332 (Pubitemid 34162999)
34. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP 2002 Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30:e15
35. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D, Vivanco I, Lee JC, Huang JH, Alexander S, Du J, Kau T, Thomas RK, Shah K, Soto H, Perner S, Prensner J, Debiasi RM, Demichelis F, Hatton C, Rubin MA, Garraway LA, Nelson SF, Liau L, Mischel PS, Cloughesy TF, Meyerson M, Golub TA, Lander ES, Mellinghoff IK, Sellers WR 2007 Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci USA 104:20007-20012
36. Team RDC 2011 R: a language and environment for statistical computing R Foundation for statistical computing. Vienna: R Foundation for Statistical Computing
37. Almeida MQ, Harran M, Bimpaki EI, Hsiao HP, Horvath A, Cheadle C, Watkins T, Nesterova M, Stratakis CA 2011 Integrated genomic analysis of nodular tissue in macronodular adrenocortical hyperplasia: progression of tumorigenesis in a disorder associated with multiple benign lesions. J Clin Endocrinol Metab 96:E728-E738
38. Gaujoux S, Tissier F, Groussin L, Libé R, Ragazzon B, Launay P, Audebourg A, Dousset B, Bertagna X, Bertherat J 2008 Wnt/β-catenin and 3′,5′-cyclic adenosine 5′-monophosphate/protein kinase A signaling pathways alterations and somatic β-catenin gene mutations in the progression of adrenocortical tumors. J Clin Endocrinol Metab 93:4135-4140
39. Tuefferd M, de Bondt A, Van den Wyngaert I, Talloen W, Göhlmann H 2011 Microarray profiling of DNA extracted from FFPE tissues using SNP 6.0 Affymetrix platform. Methods Mol Biol 724:147-160
40. Figueiredo BC, Cavalli LR, Pianovski MA, Lalli E, Sandrini R, Ribeiro RC, Zambetti G, DeLacerda L, Rodrigues GA, Haddad BR 2005 Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumors. J Clin Endocrinol Metab 90:615-619 (Pubitemid 40279170)
41. Doghman M, Karpova T, Rodrigues GA, Arhatte M, De Moura J, Cavalli LR, Virolle V, Barbry P, Zambetti GP, Figueiredo BC, Heckert LL, Lalli E 2007 Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol Endocrinol 21:2968-2987 (Pubitemid 350223508)
42. Sbiera S, Schmull S, Assie G, Voelker HU, Kraus L, Beyer M, Ragazzon B, Beuschlein F, Willenberg HS, Hahner S, Saeger W, Bertherat J, Allolio B, Fassnacht M 2010 High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors. J Clin Endocrinol Metab 95:E161-E171
43. Almeida MQ, Soares IC, Ribeiro TC, Fragoso MC, Marins LV, Wakamatsu A, Ressio RA, Nishi MY, Jorge AA, Lerario AM, Alves VA, Mendonca BB, Latronico AC 2010 Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults. J Clin Endocrinol Metab 95:1458-1462
44. Matyakhina L, Pack S, Kirschner LS, Pak E, Mannan P, Jaikumar J, Taymans SE, Sandrini F, Carney JA, Stratakis CA 2003 Chromosome 2 (2p16) abnormalities in Carney complex tumours. J Med Genet 40:268-277 (Pubitemid 36506440)
45. Kallioniemi A 2008 CGH microarrays and cancer. Curr Opin Biotechnol 19:36-40
46. Loncarevic IF, Hering A, Posorski N, Linden T, Hoyer H, Bucsky P 2008 Number of genomic imbalances correlates with the overall survival for adrenocortical cancer in childhood. Pediatr Blood Cancer 51:356-362
47. Huber W, Toedling J, Steinmetz LM 2006 Transcript mapping with high-density oligonucleotide tiling arrays. Bioinformatics 22:1963-1970 (Pubitemid 44283008)